The Michigan Radiation Oncology Quality Consortium: A Novel Initiative to Improve the Quality of Radiation Oncology Care.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 06 2022
Historique:
received: 15 11 2021
revised: 24 01 2022
accepted: 26 01 2022
pubmed: 7 2 2022
medline: 18 5 2022
entrez: 6 2 2022
Statut: ppublish

Résumé

Numerous quality measures have been proposed in radiation oncology, and initiatives to improve access to high-complexity care, quality, and equity are needed. We describe the design and evaluate effect of a voluntary statewide collaboration for quality improvement in radiation oncology initiated a decade ago. We evaluate compliance before and since implementation of annual metrics for quality improvement, using an observational data set with information from more than 20,000 patients treated in the 28 participating radiation oncology practices. At thrice-yearly meetings, experts have spoken regarding trends within the field and inspired discussions regarding potential targets for quality improvement. Blinded data on practices at various sites have been provided. Following Standards for Quality Improvement Reporting Excellence guidelines, we describe the approach and measures the program has implemented. To evaluate effect, we compare compliance at baseline and now with active measures using mixed effects regression models with site-level random effects. Compliance has increased, including use of guideline-concordant hypofractionated radiation therapy, doses to targets or normal tissues, motion management, and consistency in delineating and naming contoured structures (a precondition for quality evaluation). For example, use of guideline-concordant hypofractionation for breast cancer increased from 47% to 97%, adherence to target coverage goals and heart dose limits for dose increased from 46% to 86%, motion assessment in patients with lung cancer increased from 52% to 94%, and use of standard nomenclature increased from 53% to 82% for lung patients and from 80% to 94% for breast patients (all P < .001). Although observational analysis cannot fully exclude secular trends, contextual data revealing slow uptake of best practices elsewhere in the United States and qualitative feedback from participants suggests that this initiative has improved the consistency, efficiency, and quality of radiation oncology care in its member practices and may be a model for oncology quality improvement more generally.

Identifiants

pubmed: 35124133
pii: S0360-3016(22)00094-3
doi: 10.1016/j.ijrobp.2022.01.048
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

257-265

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Reshma Jagsi (R)

University of Michigan, Medical School, Radiation Oncology, Ann Arbor, Michigan. Electronic address: rjagsi@med.umich.edu.

Matthew Schipper (M)

University of Michigan, School of Public Health, Biostatistics, Ann Arbor, Michigan.

Melissa Mietzel (M)

University of Michigan, Medical School, Radiation Oncology, Ann Arbor, Michigan.

Raveena Pandya (R)

University of Michigan, Medical School, Radiation Oncology, Ann Arbor, Michigan.

Jean M Moran (JM)

University of Michigan, Medical School, Radiation Oncology, Ann Arbor, Michigan.

Martha Matuszak (M)

University of Michigan, Medical School, Radiation Oncology, Ann Arbor, Michigan.

Frank Vicini (F)

GenesisCare, Radiation Oncology, Farmington Hills, Michigan.

Shruti Jolly (S)

University of Michigan, Medical School, Radiation Oncology, Ann Arbor, Michigan.

Peter Paximadis (P)

Spectrum Health Lakeland, Radiation Oncology, St. Joseph, Michigan.

Brandon Mancini (B)

West Michigan Cancer Center, Radiation Oncology, Kalamazoo, Michigan.

Kent Griffith (K)

University of Michigan, School of Public Health, Biostatistics, Ann Arbor, Michigan.

James Hayman (J)

University of Michigan, Medical School, Radiation Oncology, Ann Arbor, Michigan.

Lori Pierce (L)

University of Michigan, Medical School, Radiation Oncology, Ann Arbor, Michigan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH